St Jude launches a device to shield cardiac patients from stroke
St. Jude Medical, Inc., a global medical device company, has announced the first implant of the companys Amplatzerâ„ Cardiac Plug […]
Tags: Apollo Hospital, Atrial Fibrillation, Cardiac Electrophysiology, cardiology, Director, Health/Medical/Pharmaceuticals, important tool, India, Interventional cardiology, Left atrial appendage, Left atrial appendage occlusion, Meerkin, New Delhi, non-valvular Atrial Fibrillation, senior interventional cardiologist, Shaare Zedek Medical Center, Shaare Zedek Medical Center in Jerusalem, stroke, Structural and Congenital Heart Disease Unit, Thrombus
ELIQUIS
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced on Aug 28, 2011 the main results of the Phase 3 clinical trial ARISTOTLE (Apixaban for Reduction In Stroke and Other Thromboembolic Events in Atrial Fibrillation), which uated ELIQUIS
nContact EPi-Sense device receives CE mark
nContact has received CE mark approval for its fourth generation EPi-Sense guided-coagulation device with VisiTrax for the treatment of cardiac arrhythmias, including atrial fibrillation.
Research on drugs that may curb dementia
Treating stroke survivors for a heartbeat problem called atrial fibrillation (AF) might prevent many patients from going on to develope dementia.
Biotronik MRI Products Receive European Approval
ProMRI Pacing Systems that are compatible with Magnetic Resonance Imaging (MRI) scans -Evia pacemaker series and Safio Spacing leads – have received European approval.
eCardio launches eTrigger AF 920
eCardio Diagnostics, a provider of advanced ambulatory cardiac monitoring products and services launches the eTrigger AF920 event monitor for detection of atrial fibrillation (Afib) among asymptomatic patients.
wirelesshealthcare.co.uk
eCardio Diagnostics, a provider of advanced ambulatory cardiac monitoring products and services launches the eTrigger AF920 event monitor for detection of atrial fibrillation (Afib) among asymptomatic patients.
